trending Market Intelligence /marketintelligence/en/news-insights/trending/c0tp7fi6mxgmdk9rx2xdwq2 content esgSubNav
In This List

Corvus Pharmaceuticals closes $69M public offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Corvus Pharmaceuticals closes $69M public offering

Corvus Pharmaceuticals, Inc. said it raised $69.0 million after issuing 8,117,647 shares of the company at $8.5 each, inclusive of the 1,058,823 shares granted to underwriters as part of their overallotment option.

Credit Suisse and Jefferies were acting as the joint book-running managers of the Burlingame, Calif.-based company's public offering.

Guggenheim Securities was acting as lead manager and Wedbush PacGrow was acting as co-manager.